Key Insights Institutions' substantial holdings in ESSA Pharma implies that they have significant influence over the...
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 p.m. ET in New York.
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...